sgp(schering plough) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : sgp(schering plough)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Home-Run who wrote (113)	12/15/2003 6:16:34 AM
From: Neil H	Read Replies (1) of 117

08:53 ET Schering-Plough target raised to $25 at Thomas Weisel (SGP) 16.81: Thomas Weisel reiterates their Outperform and raises their target to $25 from $23, saying results from their survey of cardiologists indicate Zetia use should increase from 11% currently to 15% of patients receiving a lipid-lowering drug. Surveyed cardiologists predict the usage of the Zetia/Zocor combination product to reach 24% one-year post-market launch, with gains coming not only from Zocor conversions but also from patients switching over from other statin treatments.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next